Opportunity OverviewThe Director of Non-personal Marketing will lead the development and execution of non-personal / digital marketing strategies that support brand awareness, engagement, and commercial objectives across the company's portfolio. This role is ideal for a strategic yet hands-on leader who thrives in a lean environment and is comfortable operating across the full non-personal / digital marketing ecosystem.
This role will partner closely with the brand teams for both indications of Bardet Beidl syndrome (BBS) and acquired hypothalamic obesity (HO), Medical, Legal/Regulatory, sales, data management, analytics, and external agency partners to ensure compliant, impactful, and insight-driven digital initiatives across HCP and patient and caregiver segments. The role reports into the VP, New Produce Planning, Marketing and Advocacy.
Responsibilities and DutiesNon-personal Promotion Strategy & Leadership- Lead the non-personal marketing vision and roadmap aligned with brand, pipeline, and corporate objectives.
- Translate brand strategies into integrated non-personal and digital plans across HCP and patient/caregiver audiences.
- Serve as the internal digital subject-matter expert, advising brand teams on best practices and innovation, including use of AI to optimize both customer impact and budget spend.
Non-personal Campaign Execution- Oversee development and optimization of digital tactics including paid media, social, SEO/SEM, and virtual engagement tools.
- Serve as the subject matter expert and collaborate with Brand teams to support website and CRM initiatives, ensuring optimal user experience and backend measurement
- Ensure seamless integration across digital touchpoints and field-enabled channels.
Governance, Compliance & Operations- Ensure all non-personal activities comply with regulatory, legal, privacy, and pharmacovigilance requirements.
- Establish and optimize digital workflows, approval processes, and standard operating procedures.
- Manage agency partners, vendors, and internal resources efficiently within budget.
Analytics & Optimization- Define KPIs and dashboards to measure non-personal promotion performance and inform decision making.
- Leverage data and insights to optimize campaigns, personalize experiences, and improve ROI.
- Drive test-and-learn approaches to continuously improve effectiveness.
Qualifications and Skills- Bachelor's degree required.
- 10+ years of pharmaceutical marketing, or combination of related industry experience, including 5+ years of non-personal / digital marketing experience.
- Rare disease experience highly preferred.
- Strong knowledge of non-personal promotion, CRM platforms, paid media, analytics, and website management.
- Proven project management skills including objective setting, prioritization, planning, timeline and budget management, and pull-though of clear action plans.
- Understanding of regulatory and compliance requirements within pharmaceutical marketing.
- Ability to work in a highly collaborative environment with cross functional stakeholders such as Regulatory, Medical, Legal, Sales, Patient Support Services, and Data Management, and Analytics.
- Self-motivated and highly energetic individual with the ability to adapt and deliver results in a fast-paced and dynamic environment.
- Ability to operate strategically while remaining hands-on in a small company environment.
- Strong critical thinking skills with a solution-oriented mindset.
This role is based out of our corporate office in Boston, Massachusetts. Rhythm operates in a hybrid-work model. Candidates applying must be willing and able to be in the Boston office in coordination with their department and business needs. This role may involve some travel.
The expected salary range for this position is $182,000-$275,000 . Actual pay will be determined based on experience, level, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and company performance. This role may be eligible for benefits and other compensation such as restricted stock units.
